Pentwater Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,000	Closed	-$880K	–	91
2023 Q1	$880K	Sell	30,000 -5,000	-14%	-$147K	0.01%	77
2022 Q4	$1.29M	Buy	+35,000	New	+$1.29M	0.02%	59